EE200300519A - Meetod pioglitasooni kui suhkurtõvevastase aine saamiseks - Google Patents

Meetod pioglitasooni kui suhkurtõvevastase aine saamiseks

Info

Publication number
EE200300519A
EE200300519A EEP200300519A EEP200300519A EE200300519A EE 200300519 A EE200300519 A EE 200300519A EE P200300519 A EEP200300519 A EE P200300519A EE P200300519 A EEP200300519 A EE P200300519A EE 200300519 A EE200300519 A EE 200300519A
Authority
EE
Estonia
Prior art keywords
sup
formula
group
residue
general formula
Prior art date
Application number
EEP200300519A
Other languages
English (en)
Estonian (et)
Inventor
Halama Ales
Hejtm�nkov� Ludmila
Lustig Petr
Richter Jindrich
Srsnov� Lucie
Jirman Josef
Original Assignee
L�civa, a.s.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20011501A external-priority patent/CZ20011501A3/cs
Priority claimed from CZ20011502A external-priority patent/CZ20011502A3/cs
Application filed by L�civa, a.s. filed Critical L�civa, a.s.
Publication of EE200300519A publication Critical patent/EE200300519A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
EEP200300519A 2001-04-26 2002-04-25 Meetod pioglitasooni kui suhkurtõvevastase aine saamiseks EE200300519A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20011501A CZ20011501A3 (cs) 2001-04-26 2001-04-26 Způsob výroby meziproduktu pro výrobu antidiabetika
CZ20011502A CZ20011502A3 (cs) 2001-04-26 2001-04-26 Způsob výroby antidiabetika
PCT/CZ2002/000024 WO2002088120A1 (en) 2001-04-26 2002-04-25 Method for obtaining pioglitazone as an antidiabetic agent

Publications (1)

Publication Number Publication Date
EE200300519A true EE200300519A (et) 2004-02-16

Family

ID=25746959

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300519A EE200300519A (et) 2001-04-26 2002-04-25 Meetod pioglitasooni kui suhkurtõvevastase aine saamiseks

Country Status (11)

Country Link
US (1) US7009057B2 (de)
EP (1) EP1387843B1 (de)
AT (1) ATE355286T1 (de)
AU (1) AU2002311057A1 (de)
DE (1) DE60218449D1 (de)
EE (1) EE200300519A (de)
HU (1) HUP0400091A2 (de)
PL (1) PL363738A1 (de)
RU (1) RU2281285C2 (de)
SK (1) SK14452003A3 (de)
WO (1) WO2002088120A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993773B2 (en) 2002-07-16 2015-03-31 Cadila Healthcare Limited Process to prepare pioglitazone via several novel intermediates
AU2003272072A1 (en) 2002-07-16 2004-02-02 Cadila Healthcare Limited A process to prepare pioglitazone via several intermediates.
WO2004108721A1 (en) * 2003-04-01 2004-12-16 Sun Pharmaceutical Industries Limited Process for the preparation of 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl] methyl]-2,4-thiazolidinedione
ES2219180B1 (es) * 2003-05-09 2006-03-01 Medichem, S.A. Compuesto intermedio util para la preparacion de pioglitazona.
US20050059708A1 (en) * 2003-05-13 2005-03-17 Karel Pospisilik Processes for making thiazolidinedione derivatives and compounds thereof
US7230016B2 (en) 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
US20070078170A1 (en) * 2003-08-28 2007-04-05 Khanduri Chandra H Process for the preparation of pioglitazone
CN1319956C (zh) * 2003-09-12 2007-06-06 深圳市海粤门生物科技开发有限公司 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用
WO2005080387A2 (en) * 2004-02-20 2005-09-01 Synthon B.V. Processes for making pioglitazone and compounds of the processes
US7402713B2 (en) * 2006-03-07 2008-07-22 E.I. Du Pont De Nemours And Company Processes for conversion of tyrosine to p-hydroxystyrene and p-acetoxystyrene
ES2388555T3 (es) 2006-03-16 2012-10-16 Metabolic Solutions Development Company Llc Análogos de tiazolidindiona
CA2646207C (en) 2006-03-16 2016-01-19 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
KR100791400B1 (ko) 2006-09-06 2008-01-07 동우신테크 주식회사 티아졸리딘디온 유도체의 제조방법
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
NZ597381A (en) 2007-09-14 2013-03-28 Metabolic Solutions Dev Co Llc Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
WO2009148195A1 (en) * 2008-06-02 2009-12-10 Daebong Ls, Ltd. 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same
HUE038042T2 (hu) 2009-12-15 2018-09-28 Cirius Therapeutics Inc PPAR helyettesítõ tiazolidindion sók metabolikus betegségek kezelésére
CN108003090A (zh) * 2018-01-05 2018-05-08 白银亿尔精细化工有限公司 一种制备4-[2-(5-乙基-2-吡啶基)乙氧基]硝基苯的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209274A (en) 1981-06-16 1982-12-22 Takeda Chem Ind Ltd Urea derivative, its preparation and its use
WO1986006069A1 (fr) * 1985-04-09 1986-10-23 Takeda Chemical Industries, Ltd. Derives de thiazolidinedione, leur procede de preparation et composition medicinale les contenant
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
JPS62205054A (ja) 1986-03-05 1987-09-09 Takeda Chem Ind Ltd 尿素誘導体
US5952509A (en) 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
JP4316787B2 (ja) * 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、

Also Published As

Publication number Publication date
HUP0400091A2 (hu) 2004-06-28
WO2002088120B1 (en) 2004-02-26
RU2003134542A (ru) 2005-06-10
PL363738A1 (en) 2004-11-29
RU2281285C2 (ru) 2006-08-10
ATE355286T1 (de) 2006-03-15
EP1387843B1 (de) 2007-02-28
SK14452003A3 (sk) 2004-04-06
US20050043360A1 (en) 2005-02-24
EP1387843A1 (de) 2004-02-11
AU2002311057A1 (en) 2002-11-11
US7009057B2 (en) 2006-03-07
WO2002088120A1 (en) 2002-11-07
DE60218449D1 (de) 2007-04-12

Similar Documents

Publication Publication Date Title
PL363738A1 (en) Method for obtaining pioglitazone as an antidiabetic agent
BG106622A (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
CO5280198A1 (es) Inhibidores a base de pirrolidina fusionada con ciclopropilo de dipeptidil peptidasa iv y metodo
LV12782B (en) Heterocyclic containing biphenyl ap2 inhibitors and method
WO2004020430A3 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
ATE348814T1 (de) Verfahren zur herstellung von chinolinderivaten
NZ524559A (en) 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
WO2000071511A3 (en) INHIBITORS OF FACTOR Xa
WO2003030886A3 (en) Allylamides useful in the treatment of alzheimer's disease
AU2002356991A1 (en) Amino acid derivatives useful for the treatment of alzheimer's disease
MXPA03001356A (es) Nuevos agentes inhibidores de beta-amiloides, procedimientos para su preparacion y su uso como medicamentos.
AU3853697A (en) N-benzenesulphonyl-l-proline derivatives as bradykinin b2 agonists
PT1222160E (pt) Processo para a preparacao de um derivado da alilamina substituido e seus sais
EP1085015A3 (de) Eine stickstoffhaltige heterocyclische Verbindung enthaltender Katalysator
DE602004008863D1 (de) Zusammensetzung und Verfahren zur Behandlung von Halbleitersubstraten
DE60219950D1 (de) Verfahren zur überwachung/bekämpfung von thysanoptera
TWI318625B (en) Process for the preparation of 2-aminomethylpyridine derivative
PT1317455E (pt) Processo para a preparacao de um composto de imidazopiridina substituido
EP1319656A4 (de) Neues verfahren zur herstellung einer chinolon-carbonsäure
WO2003062261A3 (en) Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use
EP1236709A3 (de) Verfahren zur Herstellung von Terbinafine
BR0015163A (pt) Substrato enzimático, processo de sìntese de um substrato enzimático, composição e processo para a detecção e/ou a identificação e/ou a quantificação de pelo menos um microorganismo, kit de diagnóstico e utilização de um substrato enzimático
ATE289992T1 (de) Geschützte tyrosinderivate, verfahren zu deren herstellung und deren verwendung zur herstellung von o-(2- ?18 f)-fluorethyl)-l-tyrosin
MXPA05013715A (es) Proceso para preparar derivados del acido (2s)-3-(4- {2-[amino]-2 -oxoetoxi} fenil)-2- [amino]-2 -oxoetoxi}fenil)-2 -etoxipropanoico.
PT1423385E (pt) Intermediários para preparar conjugados inibidores da neuraminidase

Legal Events

Date Code Title Description
HC1A Change of owner name